Oops! This page seems to have moved.
Our website recently re-launched, and a lot of content has been shuffled around.
We've done a search for you below to see if we can help find what you're looking for.
Searching for: 'arthritis information what is arthritis'
Tocilizumab
Tocilizumab (brand name Actemra) belongs to a new class of medicines called biological disease modifying antirheumatic drugs (biological DMARDs or bDMARDs). These medicines block natural substances called cytokines, which are found in excessive amounts in the blood and joints of people with rheumatoid arthritis. The increased levels of cytokines cause inflammation, which results in symptoms of pain, joint swelling and stiffness, and can lead to joint damage.
Secukinumab
Secukinumab (brand name: Cosentyx(r)) is a medicine used to treat adults with psoriatic arthritis, an inflammatory disease of the joints that is often accompanied by psoriasis. Secukinumab is also used to treat adults with moderate to severe plaque psoriasis that is chronic (lasts for a long time). Secukinumab may also be used to treat adults with ankylosing spondylitis, an inflammatory disease which primarily affects the spine, causing inflammation and pain in the spinal joints.
Pregnancy
Get the information you need about arthritis (including rheumatoid arthritis, osteoarthritis, lupus, ankylosing spondylitis) and pregnancy, conceiving, fertility, labour and delivery, and breastfeeding.
Ixekizumab
Ixekizumab (brand name: Taltz®) is a medicine used to treat adults with psoriatic arthritis, an inflammatory disease of the joints that is often accompanied by psoriasis. Ixekizumab is also used to treat adults with moderate to severe plaque psoriasis that is chronic.
Anakinra
Anakinra (brand name Kineret) belongs to a new class of medicines called biological disease modifying antirheumatic drugs (biological DMARDs). These medicines block natural substances called cytokines, which are found in excessive amounts in the joints of people with rheumatoid arthritis or juvenile/childhood arthritis.
Abatacept
Abatacept (brand name Orencia) belongs to a new class of medicines called biological disease modifying antirheumatic drugs (biological DMARDs or bDMARDs). These medicines block natural substances called cytokines, which are found in excessive amounts in the blood and joints of people with rheumatoid arthritis and juvenile arthritis.
Golimumab
Golimumab (brand name Simponi) belongs to a class of medicines called biological disease modifying antirheumatic drugs (biological DMARDs or bDMARDs). These medicines block substances, produced by arthritic tissues, called cytokines. These cytokines are found in excessive amounts in the blood and joints of people with rheumatoid arthritis, psoriatic arthritis, juvenile arthritis and ankylosing spondylitis.
Etanercept
Etanercept belongs to a class of medicines called biological disease modifying antirheumatic drugs (biological DMARDs or bDMARDs). hese medicines block substances, produced by arthritic tissues, called cytokines. These cytokines are found in excessive amounts in the blood and joints of people with rheumatoid arthritis, psoriatic arthritis, juvenile arthritis and ankylosing spondylitis.
Guselkumab
Guselkumab belongs to a class of medicines called biological disease-modifying antirheumatic drugs (biological DMARDs or bDMARDs). People with psoriatic arthritis and psoriasis have increased levels of a protein called interleukin-23 (IL-23) which can cause pain and swelling in the joints. Guselkumab works by blocking the activity of IL-23 and hence reduces the inflammation. Guselkumab is...
Upadacitinib
Upadacitinib (brand name: Rinvoq®) is a tablet that belongs to a class of medicines called Janus Kinase (JAK) inhibitor. JAK inhibitors work by blocking signals involved in inflammation. Blocking these signals in Rheumatoid Arthritis reduces pain, stiffness, swelling and damage in the joints.
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
